- Email:
Custom Neural Differentiation Services
Introduction
The shift from 2D cultures to 3D ex vivo models mark a paradigm change in CNS research. Studies show that iPSC-derived neural progenitors exert therapeutic effects via the secretome and extracellular vesicles. Creative Biolabs provides custom neural differentiation with high-purity neural cells and mature functional subtypes. Its advanced STEMOD™ platform and transcription-factor programming help build patient-specific models, bridge translational gaps, and support accurate disease modeling and drug screening to accelerate CNS therapeutic development.
Discover How We Can Help - Request a Consultation
Custom Neural Differentiation Services
Our Custom Neural Differentiation Service leverages human iPSC technology to generate highly pure, physiologically relevant neural cell populations under standardized and customizable induction systems. These stage-specific neural cells faithfully simulate in vivo neurodevelopmental processes, providing ideal cell materials for disease modeling, drug screening, and mechanistic studies.
Fig.1 Developmental origins of central nervous system cell types.1
Neural Rosette Differentiation
Induces and establishes structured neural rosettes from pluripotent stem cells, mimicking early neural tube development. Serves as a foundational step for generating all downstream neural lineages.
Neuronal Progenitor Differentiation
Produces stable and expandable neuronal progenitor cells with high purity, supporting further differentiation into various functional neurons for neural development and repair research.
Glial Progenitor Differentiation
Generates glial progenitor cells capable of developing into astrocytes and oligodendrocytes, supporting studies on myelination, neuroinflammation, and glia-neuron interactions.
GABAergic Neuron Progenitor Differentiation
Directs differentiation toward GABAergic neuron progenitors, ideal for investigating inhibitory circuit formation, epilepsy, autism, and related neuropsychiatric disorders.
Applications
- Recapitulation of early neural development processes
- Disease modeling for neurodevelopmental and neurodegenerative disorders
- High-throughput drug screening and neurotoxicity evaluation
- Cell therapy research and candidate validation
- Gene editing and mechanism research in neural lineages
Workflow
Our process is a highly collaborative and technical journey designed to ensure the resulting neural models meet the rigorous demands of pharmaceutical R&D.
What We Can Offer
At Creative Biolabs, we provide a robust ecosystem for neural modeling that scales from basic discovery to industrial-grade validation. Our offerings include:
One-stop differentiation service
from small-scale pilot studies to high-volume neural cell production for HTS
Efficient upstream and downstream process development
for lineage-specific patterning (e.g., GABAergic, Glutamatergic, Dopaminergic)
Large-scale cell banking capability
ensuring the long-term stability and genetic integrity of your specific iPSC-derived lines
Well-established quality system
utilizing Quality-by-Design (QbD) and Process Analytical Technology (PAT) to monitor neural maturation
Optimized codon usage and CRISPR/Cas9 integration
for the development of customized fluorescent reporter or disease-mutant lines
Strict aseptic verification and QC procedures
throughout the differentiation process to guarantee zero mycoplasma or viral contamination
Flexible culture modes
including 2D monolayer, 3D organoid, or microfluidic BBB-on-chip systems tailored to your study
All-side documentation and traceability
for all cell lines, ensuring compliance with rigorous scientific and ethical standards
Experience the Creative Biolabs Advantage - Get a Quote Today
Customer Reviews
FAQs
Q: How do you ensure the maturity of the differentiated neurons?
A: We utilize a combination of prolonged maturation media and electrophysiological validation (MEA). Unlike standard services that stop at the progenitor stage, we can provide neurons that exhibit spontaneous firing and synaptic vesicle recycling.
Q: Can you differentiate cells from my specific patient-derived iPSC lines?
A: Yes, we specialize in custom projects. You can ship your proprietary lines to our facility, and our experts will optimize a differentiation protocol specifically for your genetic background.
Q: How does your service compare to using primary rodent neurons?
A: Primary rodent cells often fail to replicate human-specific drug responses. Our human iPSC-derived cells provide a more accurate genetic and physiological context, strongly reducing the risk of clinical attrition.
Q: Are the cells provided in a ready-to-use format?
A: Yes. We can provide cells at various stages, including cryopreserved progenitors or "ready-to-assay" adherent cultures in 96-well or 384-well plates for immediate screening.
Q: What precautions are taken regarding the Blood-Brain Barrier (BBB) models?
A: Our BBB models include endothelial cells, pericytes, and astrocytes. We measure Trans-endothelial Electrical Resistance (TEER) to ensure the integrity of the barrier before you begin your transport studies.
Creative Biolabs offers a suite of neural engineering services, ranging from basic progenitor derivation to the development of complex brain organoids and BBB-on-chip models. We provide the tools necessary to unlock the secrets of the human brain through precision, reliability, and scientific excellence.
Contact Our Team for More Information and to Discuss Your Project
Reference
- McDaid, Georgie, et al. "Transcription Factor-Based Differentiation of Pluripotent Stem Cells: Overcoming the Traps of Random Neuronal Fate." Biomedicines 13.11 (2025): 2783. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/biomedicines13112783.
For Research Use Only. Not For Clinical Use.